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Abstract
Background: In a recent study, two-dimensional (2D) network layouts were used to visualize and quantitatively
analyze the relationship between chronic renal diseases and regulated genes. The results revealed complex
relationships between disease type, gene specificity, and gene regulation type, which led to important insights
about the underlying biological pathways. Here we describe an attempt to extend our understanding of these
complex relationships by reanalyzing the data using three-dimensional (3D) network layouts, displayed through 2D
and 3D viewing methods.
Findings: The 3D network layout (displayed through the 3D viewing method) revealed that genes implicated in
many diseases (non-specific genes) tended to be predominantly down-regulated, whereas genes regulated in a
few diseases (disease-specific genes) tended to be up-regulated. This new global relationship was quantitatively
validated through comparison to 1000 random permutations of networks of the same size and distribution. Our
new finding appeared to be the result of using specific features of the 3D viewing method to analyze the 3D renal
network.
Conclusions: The global relationship between gene regulation and gene specificity is the first clue from human
studies that there exist common mechanisms across several renal diseases, which suggest hypotheses for the
underlying mechanisms. Furthermore, the study suggests hypotheses for why the 3D visualization helped to make
salient a new regularity that was difficult to detect in 2D. Future research that tests these hypotheses should
enable a more systematic understanding of when and how to use 3D network visualizations to reveal complex
regularities in biological networks.
Findings
Introduction
Several studies have analyzed how diseases such as
breast cancer [1-3] and leukemia [4] are similar or dif-
ferent at the molecular level. Such studies have led to
improvements in the classification of diseases [5,6], and
targeted treatment options [2,4,7]. However, little is
known about how combinations of chronic renal dis-
eases are similar or different at the molecular level.
To address this lack of understanding, in a recent
study [8] we used 2D network visualizations and
quantitative analyses to understand how 747 mRNA
transcripts (henceforth referred to as genes) were regu-
lated across 7 chronic renal diseases. Figure 1A shows
the network that we generated and analyzed. Here the
nodes represent diseases or genes, and an edge between
them represents either an up or down regulation. The
size of the nodes is proportional to the number of edges
connected to them (node degree). Therefore large dis-
ease nodes (high degree) have relatively many associated
genes, whereas small disease nodes (low degree) have
few associated genes.
The network analysis revealed three unexpected regu-
larities, with possibly important domain implications. (1)
Many genes were associated with a single disease (dis-
ease-specific genes) and fewer genes were associated
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reproduction in any medium, provided the original work is properly cited.Figure 1 2D and 3D Layout of the Renal Network. The renal bipartite network laid out by the Fruchterman-Reingold [18] algorithm in 2D (A), and in 3D (B) showing the relationship
between 7 renal diseases (white nodes), and 747 genes (black nodes). The size of each node is proportional to the number of its connected edges so diseases with many genes have large
nodes, and diseases with few genes have smaller nodes. A yellow edge represents that the connected gene is up-regulated, and a blue edge represents that the connected gene is down-
regulated. The 3D network layout enables more spreading out of nodes (as shown by the greater area used by the down-regulated genes in the centre of the 3D network), but also tends to
occlude node labels.
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9with many diseases (non-specific genes). This regularity
related to gene degree resulted in a right skewed gene
degree distribution. The many disease-specific genes
suggested that the current classification (based on simi-
larities in morphology, pathophysiology, or serology) is
reflective of specific molecular mechanisms, whereas the
few non-specific genes indicate the presence of one or
more common mechanisms activated in chronic kidney
disease. (2) There were unexpected combinations of
renal diseases, genes, and regulation type. For example,
there were four renal diseases (SLE, FSGS, MGN, IgAN)
that shared many genes, which tended to be down-regu-
lated. This regularity related to disease type and regula-
tion type suggested the presence of a shared molecular
mechanism between two different classes of diseases:
mostly inflammatory (SLE, IgAN) and mostly non-
inflammatory diseases (FSGS, MGN). (3) There was uni-
form concordance in gene regulation (genes were either
up or down regulated across diseases). This regularity
related to regulation type s u g g e s t e dt h a tt h es h a r e d
mechanisms have identical effects on genes regulation,
and could in the future help to identify molecular
diagnostic markers.
Our network analysis therefore revealed complex and
unexpected relationships between gene degree, disease
type, and regulation type, which led to important
insights about chronic renal diseases. Subsequent ana-
lyses confirmed that these relationships were unlikely to
have occurred by chance. (1) A comparison to 1000 ran-
dom networks of the same size (number of nodes and
edges), but with edges randomly assigned to pairs of
nodes, revealed a low probability (p < .05) of the
observed gene degree distribution occurring by chance.
(2) A comparison to 1000 random networks of the same
size, and gene and disease degree distribution (to ensure
the same number of high degree genes and diseases)
revealed a low probability (p < .001) of 4 diseases having
mostly down-regulated genes occurring by chance. (3) A
comparison to 1000 random networks of the same size,
degree distributions, and proportion of up and down
regulated genes revealed that there was a low probability
(p < .001) of the observed 100% concordance in gene
regulation occurring by chance.
Although we used quantitative methods to analyze
each of the above relationships, our main insights about
the disease-gene relationships emerged from visually
inspecting the 2D network layout. However it is well
known [9] that such layouts are limited compared to
laying out the same network in 3D. For example, nodes
that are densely packed close to each other in 2D can
be spread out in 3D to help the analyst detect more
complex regularities. We therefore explored if we could
deepen our understanding of genes regulated in renal
diseases by using 3D network layouts.
While 3D appeared intuitive and appealing, several
studies within the information visualization and cogni-
tion communities have reported conflicting results of its
value in comprehending information [10]. For example,
recent cognitive research has shown that users perform-
ing network-based tasks on 3D networks through
stereoscopic visualizations outperform users who have
access only to 2D visualizations of the same data [9].
However, others argue that the added cost of generating
and learning how to analyze 3D networks far outweighs
the expected benefits, and point to alternate 2D repre-
sentations for networks that could potentially achieve
the same results [11]. Within the bioinformatics com-
munity, most of the published literature on 3D has
focused on building tools([e.g.,[12,13]). Therefore, there
is currently neither consensus on the value of 3D to
analyze complex datasets, nor consensus on how best to
use such visualizations to analyze biological networks.
Furthermore, to the best of our knowledge, none of the
studies have demonstrated the value of 3D visualizations
to reveal novel insights.
We therefore decided to use 3D network visualizations
to reanalyze the 2D network of renal diseases and genes
that we had recently published. Our primary goal was to
explore if we could discover new patterns in the data
that were missed in our earlier 2D network analysis.
Our secondary goal was to develop hypotheses related
to the pros and cons of using 3D network visualizations
to analyze biological networks.
Method
To deepen our understanding of what we already under-
stood about chronic renal diseases and genes, we posed
the following research question: What is the relationship
between chronic renal diseases, gene regulation, and gene
specificity?
To address our research question, we made critical
decisions regarding data selection, data representation,
data viewing, and data analysis.
Data Selection
We conducted a secondary analysis on a dataset of 747
genes differentially regulated in 7 renal diseases. Tran-
scriptomic data were obtained from 106 patients with
one of seven chronic renal diseases, and were compared
to biopsies from healthy kidney donors (control). (Please
see the original study [8] for a description of the gene
expression analysis, and criteria for determining up and
down gene regulation.)
Data Representation
Networks have become ubiquitous in the analysis and dis-
covery of a wide range of molecular phenomena such as
gene regulation [14], disease-gene associations [15], and
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to as a graph in mathematics) consists of a set of points or
nodes, joined in pairs by lines or edges; nodes represent
one or more types of entities (e.g., diseases or genes).
Edges between the nodes represent a specific relationship
between the entities (e.g., a disease is significantly corre-
lated with a gene). Figure 1A shows a bipartite 2D network
[17] (where edges exist only between two different types of
entities) of diseases and their implicated genes that we
analyzed in our earlier study [8].
Networks enable multiple variables to be visually repre-
sented in the same representation thereby enabling the
discovery of complex relationships. For example, the net-
work in Figure 1A visually represents the number of genes
associated to a disease by proportionally sizing the dia-
meter of the disease nodes (large disease nodes have many
implicated genes, and small disease nodes have only a
few); the type of gene regulation is represented by the col-
our of the edges that connect a disease and gene node (a
yellow edge represents that the connected gene is up-regu-
lated, and a blue edge represents that the connected gene
is down-regulated). Furthermore, the network representa-
tion enables the layout of the nodes in Euclidean space
using powerful force-directed algorithms that pull together
nodes that share the same neighbours, and push apart
nodes which do not. Such algorithms often result in lay-
outs where the relative distances between the nodes are
meaningful in revealing complex patterns in the network.
For example, the network in Figure 1A was laid out using
t h eF r u c h t e r m a n - R e i n g o l d[ 1 8 ]( F R )a l g o r i t h mi nP a j e k
version 1.23, which resulted in genes that were shared by
many diseases to be pulled to the centre of the network,
and genes that were specific to a disease to be pushed to
the periphery of the network. These advantages make net-
works useful and versatile to represent and analyze a wide
range of complex relationships in biological datasets.
A ss h o w ni nF i g u r e1 B ,t h ea b o v en e t w o r kw a sa l s o
reconstructed by using the 3D version of the FR algo-
rithm. The third dimension enables the algorithm to lay
out the nodes such that edge crossings are reduced, a
feature that is commonly considered desirable to
enhance the readability of networks [9,10]. For each
node, the algorithm outputs x, y and z coordinates,
which are used to create the 3D network.
Data Viewing
The 3D network was viewed using two different viewing
methods:
2D Viewing and Navigation
The 3D network was viewed in 2D on a computer
screen using the Pajek viewer. Similar to a Virtual Rea-
lity Modelling Language (VRML) viewer, the Pajek
viewer enables the network to be rotated horizontally
and vertically, and to be zoomed in and out.
3D Viewing and Navigation
As shown in Figure 2, the 3D network was also viewed
in a 3D immersive environment called the Cave Auto-
matic Virtual Environment (CAVE) [19]. The goals of
this environment are to create the illusion that the
viewer is looking at a physical object in perspective, and
to enable the viewer to navigate around those virtual
objects. These goals are achieved through five standard
CAVE functionalities: (1) Stereoscopic visualization
which is achieved by projecting separate left and right
eye images of each object that are combined for the
viewer with special eye glasses. This provides an illusion
of the network objects as volumes in 3D space. (2) Mag-
nification of the network enabling greater visibility of
node and edge properties. (3) Wide field-of-view
achieved by projection of the images on the inside of
four surfaces (left, right, front, and floor) of a
10’x10’x10’ room. This enables the viewer to see objects
with a full natural field-of-view, in addition to the
option of increasing this field by turning the head to
look at objects above, below, sideways and behind. (4)
Motion sensors on the eye glasses worn by the viewer
enabling the viewer to walk within the CAVE, which
responds by automatically detecting the location of the
viewer and adjusting the perspective for the image that
is being viewed. (5) Hand-held controls which enables
the viewer to zoom, and rotate the network.
To visualize our 3D network in the CAVE, we created
a program that translated the 3D output from Pajek,
into one that can be processed by the CAVE system.
T h i sw a sd o n eb yu s i n gt h eO p e n S GA P Ii nC + + ,a
standard approach for CAVE applications.
Data Analysis
We analyzed the 3D networks using the following two
steps:
1. Visual Analysis
The networks in both viewing modes (2D and 3D
CAVE) were visually analyzed using the navigation fea-
tures each provided with the goal of detecting visual
patterns in the data. In each case the network was not
altered in any way such as by removing or highlighting
nodes. Instead, the network was viewed as a whole to
identify patterns such as node clusters, and patterns in
edge colouring.
2. Quantitative Analysis
To obtain a precise understanding of the observed visual
patterns, they were quantitatively analyzed. Because we
identified a new pattern involving gene node degree and
regulation type, we plotted a curve whose X-axis repre-
sented the gene degrees, and whose Y-axis represented
the proportion of down-regulated edges for each degree.
We then compared this curve to the same curve gener-
ated from 1000 random networks where we preserved
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(number of edges connected to a node) distribution, and
the number of up and down regulated edges. However,
we randomly labelled the edges as being either up or
down regulated. To test whether the pattern we
observed could have occurred randomly, we determined
99.9% confidence intervals around each point on the
curve.
Results
In the introduction, we briefly presented our prior
results that were based on 2D network analysis. The fol-
lowing are the new results based on 3D network
analysis.
3D Network Layout Viewed in 2D
We visually analyzed the 3D network layout using the
Pajek viewer on a desktop computer screen, and rotated
the network in an attempt to look for regularities.
Figure 1B shows the network rotated horizontally. These
actions revealed three important artefacts of the 3D lay-
out viewed in 2D. (1) Several of the nodes were
occluded by edges located in front of them, and their
labels were not visible. For example, the disease node
SLE to the far left is occluded with edges in front, and
its label is not visible. (2) The disease nodes were not in
the same location as in the 2D layout, causing us to
become disoriented mainly because we had over-learned
the location of the disease nodes in the 2D layout. (3)
Continuous rotation of the network enabled us to per-
ceive the 3D nature of the layout. However it was diffi-
cult to read the node labels that were moving across the
screen, and further contributed to our disorientation.
Furthermore, when we stopped rotating the network,
the 3D effect was lost due to lack of parallax (close
objects moving faster compared to distant objects), and
the network became partially un-readable due to edge
crossings and node occlusions. (4) Zooming into the
network led to additional confusion as it was difficult to
comprehend the relationship between the zoomed in
elements, and the entire network.
Despite the disorientation caused by viewing the 3D
layout in 2D, we did confirm global regularities that we
had identified in the 2D layout. There indeed was uni-
form concordance in gene regulation, and four of the
diseases did have many down-regulated genes as shown
by the mass of blue edges. However due to the disorien-
tation and occlusions, we were unable to identify any
new regularities.
3D Network Layout Viewed in the CAVE
Visual Analysis
We first analyzed the network in the CAVE by zooming
out to see the entire network. Next, as shown in Figure 2,
Figure 2 The 3D Renal Network Viewed Inside the CAVE. The 3D network being visualized in the CAVE through the use of stereoscopic
glasses with motion sensors, and hand-held controls for rotating, and zooming in and out of the image. For clarity, the stereoscopic double
image of each element has been turned off. The white nodes represent diseases, the purple nodes represent genes, and the yellow and blue
edges represent up and down regulation respectively. The high magnification, wide field of view, and stereoscopic display helped to reveal the
relationship between gene node degree (shown by the size of the purple gene nodes) and regulation type (shown by the blue and yellow
edges that connect the gene and disease nodes).
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towards the centre to inspect the high density of down-
regulated genes (blue edges) connected to the four dis-
eases. The image in Figure 2 obviously can neither repli-
cate the illusion of the network being a solid object
provided by the stereoscopic effect, nor convey the
immersive experience of being inside the network. We
will therefore attempt to describe in words to the best of
our ability the visual experience and our findings.
Our navigation of the 3D network inside the CAVE
led to three key observations. (1) The large screens and
zooming enabled us to look at the gene and disease
nodes at a higher magnification compared to what is
possible on a desktop or laptop screen. (2) Despite the
zooming into the network, we were still able to see the
rest of the network by merely turning our head. There-
fore, we could perceive details in the network such as
the labels and the node sizes, while simultaneously see-
ing the rest of the network, a phenomenon referred to
as focus plus context [20]. Achieving a similar level of
f o c u sp l u sc o n t e x ti sn o tp o ssible on a typical desktop
s c r e e n .( 3 )T h es t e r e o s c o p i ce f f e c te n a b l e dag r o u po f
genes with degree 4 and their edges to “pop-out” mak-
ing them easily distinguishable from other nodes and
edges. Therefore there was no need to rotate the net-
work to distinguish nodes and edges from those behind
or in front of them.
The above visual effects led to three new insights:
1. Because of the magnification of the network visuali-
zation in the CAVE, the gene nodes that had mostly
blue edges (down-regulated) were clearly larger in size
(high degree) compared to most other gene nodes.
These differences in node size were not easily percepti-
ble when viewing the network in 2D in a smaller view-
ing area. This relationship became even more salient
when we noticed two even larger gene nodes of degree
five that were both down-regulated.
2. The above relationship between high degree genes
and down-regulation was inverted when we moved our
head to look at genes that were smaller in size (low
degree) as they were mostly connected to yellow edges
(up-regulated). Therefore our earlier analysis, which
revealed the relationship between disease type and regu-
lation type (four diseases had mostly down-regulated
genes), failed to reveal the current relationship between
gene degree and regulation type (high degree genes were
mostly down-regulated, and low degree genes were
mostly up-regulated).
3. The high magnification and stereoscopic effect in
the CAVE, in addition to the discovery of the above pat-
tern, also helped to quickly identify 11 high degree
genes that did not fit the above trend. Each of these
genes was up-regulated as shown by their yellow edges
in Figure 2.
Quantitative Analysis
The solid curve in Figure 3 shows the proportion of
down-regulated genes for degrees 1-4. As there were
only two genes of degree 5 which is too low for statisti-
cal comparison, they have been omitted from the graph.
However, both of these 5 degree genes were down-regu-
lated and therefore follow the overall trend. Most
importantly, the proportion of down-regulated degree 4
genes was well above the 99.9% confidence interval, sug-
gesting the low likelihood of the observed pattern occur-
ring by chance.
Discussion
An important goal of analyzing the regulation of genes
across diseases is to identify hypotheses that could lead
to the identification and discovery of disease regulatory
pathways. Here we first discuss how the new results
compare to our previous results, followed by the new
results and related hypotheses.
As discussed in the introduction, our previous analysis
of the same data helped to reveal two regularities that
were relevant to the current findings. The first regularity
was related to gene degree: There were many disease-
specific genes, and few non-specific genes. The second
regularity was related to disease type and regulation
type: There were four renal diseases that had a high
number of down-regulated genes. The current analysis
helped to reveal a new regularity that combined
Figure 3 The Relationship between Gene Degree and the
Proportion of Down-Regulated Genes in the Renal Network.
The proportion of down-regulated genes is much larger in high
degree genes, compared to low degree genes. This pattern is
significantly different from that generated from 1000 random
networks of the same size and distribution. Two genes of degree 5
have been eliminated from the graph due their low number,
making them inappropriate for the statistical comparison. However,
as both of degree 5 genes were down-regulated, they follow the
overall trend shown.
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regulation type: Disease-specific genes tended to be up-
regulated, whereas the non-specific genes tended to be
down-regulated, with a low likelihood of this pattern
occurring by chance.
What can explain this new finding based on our gen-
eral understanding of gene regulatory pathways? It is
well established that the up-regulation of genes acting
together in a transcriptional cascade is often associated
with the activation of a particular pathway. Our observa-
tion that disease-specific genes tended to be up-regu-
lated suggests the existence of regulatory pathways that
are specific to renal diseases, each involving those up-
regulated genes. In contrast, the presence of non-specific
genes which tended to be down-regulated genes could
be the result of the loss of differentiated cell function in
diseased patients. An alternate explanation is that the
shared down-regulated genes reflect a common process
involving the loss of protective mechanisms uniformly
across several chronic renal diseases. This observation
complements other studies that have reported the loss
of protective mechanisms in diabetic nephropathy. For
example, the suppression of the protective SOCS pro-
teins in renal patients has been shown to lead to the
activation of the JAK/STAT pathway, which is consid-
ered an important mechanism by which hyperglycemia
contributes to renal damage [21,22]. Finally, the results
could also suggest the presence of one or a few suppres-
sor genes among the 11 non-specific up-regulated genes
that are responsible for the down-regulation of many
non-specific genes.
In summary, the presence of disease-specific genes
that are mostly up-regulated suggests the existence of
regulatory pathways that are specific to diseases, each
involving those up-regulated genes. In contrast, the pre-
sence of non-specific genes that are mostly down-regu-
lated could be explained by (a) the loss of differentiated
cell function, (b) the loss of protective mechanisms that
are common to many chronic renal diseases, or (c) the
presence of suppressor genes responsible for the down-
regulation of many non-specific genes. These findings
provide independent support for an international multi-
center research trial [23] that is currently underway
which tests these and related hypotheses.
Finally, the 11 high-degree genes (associated with 4
and 5 diseases) that did not follow the above pattern
motivated us to scrutinize them more closely. An analy-
sis revealed that 5 of the 11 genes (or their molecular
families) are already known to be associated with
chronic renal diseases. (a) TNFRSF11B and TNFSF10
are members of the tumour necrosis factor super family,
which is known to be associated with diabetic kidney
disease [24], lupus nephritis, and ANCA-associated glo-
merulonephritis [25]. (b) CFB and C1 S are members of
the complement system that is activated in several glo-
merular immune-complex diseases, and in progressive
tubulointerstitial fibrosis [26], a feature of several
chronic renal diseases in our data.(c) COL4A2 is an iso-
form of collagen type IV whose mutations have been
found to alter the glomerular basement membrane
directly affecting glomerular filtration, and thereby renal
function [27].
The overall result, which was the direct outcome of
re-analyzing the network in 3D, has therefore helped to
identify hypotheses about the associations among genes,
regulation type, and chronic renal diseases. These
focused hypotheses could be the basis of future experi-
ments that could reveal disease-specific mechanisms, in
addition to the common mechanisms across chronic
renal diseases.
In addition to the above hypotheses related to the
renal network, we arrived at hypotheses related to the
role of different 3D visualization functionalities in
exploratory network analysis. Given the conflicting
results and debates surrounding 2D versus 3D visualiza-
tions, we had a healthy scepticism regarding the value of
3D visualizations for discovering new regularities in our
network. However, while we were not surprised that the
3D networks viewed in 2D had limited value, we were
surprised how rapidly the same 3D network visualized
in a CAVE helped reveal new regularities the network.
In the process, we developed insights into the role of
specific functionalities offered by the CAVE for disco-
vering patterns in networks.
Our experience suggests that the stereoscopic visuali-
zation helped to distinguish nodes and edges of interest
from surrounding elements, without having to rely on
rotations that left us disoriented when viewing the net-
w o r ki n2 D .I na d d i t i o n ,t h eh i g hmagnification (as
shown by the relatively large purple nodes in Figure 2
despite the entire network being visible) helped us
notice the small changes in the size of the gene nodes
(whose degrees had a narrow range of 1-5), and alerted
us to the possibility of the global regularity. This small
change in node degree was difficult to detect at the
scale of a typical computer screen where the gene node
diameter is in the range of a few pixels when the entire
network is visible. Finally, the wide field-of-view
enabled us to look at details of the nodes such as their
labels and connections, without losing context of the
entire network. This feature therefore resolved the focus
versus context trade-off required on normal computer
screens, and enabled us to quickly detect the global reg-
ularity relating gene degree and regulation type. Future
research should control for each of these features to
specifically identify their role in not just simple tasks
such as path tracing typically used in experiments, but
also for more complex tasks such as the discovery of
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similar to what we discovered.
It is important to note that our 2D networks reported
in our earlier study had been closely analyzed by two
computer scientists experienced in network analysis, two
renal experts, and subsequently reviewed in two cycles
before journal publication. Therefore, while the pattern
might appear obvious in hindsight, we believe that the
CAVE provided critical features to help rapidly discover
new patterns, a hypothesis that needs to be tested
through future controlled studies.
The limitation of our study was that we relied on the
features of current 2D and 3D viewers commonly avail-
able, and it is possible that future development could
enhance such desktop applications to help in the rapid
identification of patterns in 3D networks. The reasons
o fw h yw ef o u n ds p e c i f i cC AVE features most useful
could provide the starting point for the design of future
desktop applications that could avoid the high cost of
building and using a CAVE.
Conclusion
The analysis discussed in this article helped to identify a
new global regularity that related gene degree and regu-
lation type, which had a low likelihood of occurring by
chance, and which was of domain importance. Further-
more, the study suggests that immersive 3D visualiza-
tions could help to identify new regularities that can be
easily missed when relying solely on 2D network analy-
sis. Future research should explicitly test this finding
through controlled experiments. Towards that goal, this
study helped to identify testable hypotheses about the
role played by different visualization functionalities
offered by 3D immersive environments to help identify
complex regularities in biological networks. In addition,
we believe that future experiments that evaluate 3D
visualization methods could benefit by using the realistic
patterns and the network discussed in this article. By
using realistic but doable tasks, such experiments should
lead to the next generation of visualization tools that
enable bioinformaticians to quickly identify complex
patterns in real-world biomedical data, leading to poten-
tially important breakthroughs in the treatment of
chronic diseases.
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